Cynvenio Biosystems' Series B - IV Round

Cynvenio Biosystems raised a round of funding on January 28, 2014. Investors include Amgen Ventures.

Cynvenio Biosystems, formerly CytomX, is focused on the development of the LiquidBiopsy platform, a high performance rare cell isolation technology for biomedical research and cancer diagnostics. Liqu…

Articles about Cynvenio Biosystems' Series B - IV Round: